awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33604322-82224B3A-637F-4409-805F-A2B43DC71B6B
Q33604322-82224B3A-637F-4409-805F-A2B43DC71B6B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33604322-82224B3A-637F-4409-805F-A2B43DC71B6B
Simplification to abacavir/lamivudine + atazanavir maintains viral suppression and improves bone and renal biomarkers in ASSURE, a randomized, open label, non-inferiority trial
P2860
Q33604322-82224B3A-637F-4409-805F-A2B43DC71B6B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33604322-82224B3A-637F-4409-805F-A2B43DC71B6B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0a39eb92d7ab81580d53f0348c1fd87939fd7729
P2860
Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz.